Enlie Pharmaceutical JSC (BCP.VN) Stock Price
Enlie Pharmaceutical JSC Price
Over the last 10 years Enlie Pharmaceutical JSC grew revenue by 5.9% annually, reaching 147.03 B VND. Earnings per share have declined at 25.4% per year over the last 10 years. For Enlie Pharmaceutical JSC, the net margin of 0.2% is up versus -21.3% a few years ago.
Enlie Pharmaceutical JSC stock price
Enlie Pharmaceutical JSC business model & stock analysis
Frequently asked questions about Enlie Pharmaceutical JSC
Converted at the current exchange rate, the Enlie Pharmaceutical JSC share trades at 0.28 EUR (8,000.00 VND).
The revenue cannot currently be calculated for Enlie Pharmaceutical JSC.
The profit cannot currently be calculated for Enlie Pharmaceutical JSC.
The P/E ratio cannot be calculated for Enlie Pharmaceutical JSC at the moment.
The P/S cannot be calculated for Enlie Pharmaceutical JSC currently.
The Eulerpool Quality Score for Enlie Pharmaceutical JSC is 3/10.
The ISIN of Enlie Pharmaceutical JSC is VN000000BCP6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Enlie Pharmaceutical JSC is BCP.VN. The ticker symbol is used to trade Enlie Pharmaceutical JSC shares on the stock exchange.
Enlie Pharmaceutical JSC stock
Enlie Pharmaceutical JSC Peer Group
Enlie Pharmaceutical JSC FIGI
All fundamentals and in-depth analysis of Enlie Pharmaceutical JSC
Our stock analysis for Enlie Pharmaceutical JSC stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enlie Pharmaceutical JSC. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.